Older adults diagnosed with autism face a significantly higher risk of developing Parkinson’s disease-related movement ...
Owen’s family watched him change from a happy and energetic child to one who was often moody and unhappy. His parents were told he had autism, but they sensed something was missing in ...
The brain-gut axis is being studied for its potential role in autism-related communication difficulties, although evidence ...
A registered randomized controlled trial protocol outlines a 12-week interactive exercise intervention for children with ...
A four-year old US boy’s life – and that of his family – has been completely transformed since he started treatment on a “miracle drug” for his severe autism four months ago, reports New York Post.
People with autism report more severe menopause symptoms, higher anxiety, and poorer quality of life, highlighting a need for ...
The Melbourne company dosed the first patient in its Beyond Harmony study of NTI164 on 21 September. All six sites across ...
Health and Me on MSN
‘Ozempic of autism’: Experimental drug shows symptom improvements in nonverbal boy with ASD
L1-79 is an oral drug developed by Yamo Pharmaceuticals to target autism’s core symptoms. About 116 patients have reportedly ...
A particular signaling protein in the brain could be a therapeutic target for neurological disorders arising from the ...
Idorsia Ltd. is branching into a new indication for its dual orexin 1 and 2 antagonist drug Quviviq (daridorexant), after a phase II pediatric insomnia trial showed unexpected improvements in the ...
An experimental comparison of 17 autism-risk mouse lines identified two opposing brain-gene activity states that varied with ...
An oral drug designed to treat the core symptoms of autism spectrum disorder, has been dubbed by some as 'the Ozempic of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results